– CANADA, Mississauga – Nuvo Pharmaceuticals Inc. (TSX: MRV | OTC: MRVFF), dba. Miravo Healthcare today announced the appointment of Anthony Snow to its Board of Directors, on August 12, 2022.
“Anthony is our first U.S.-based board member and brings to the organization new perspectives and a wealth of capital markets experience. As a representative of our largest shareholder, Anthony’s interests are very much aligned with all shareholders,” said Board Chair, Rob Harris.
CEO, Jesse Ledger, added, “We are pleased to welcome Anthony to Miravo’s Board of Directors. With more than 20 years of North American investing and capital markets experience, Anthony will be a strong addition to our board.”
About Anthony Snow
Anthony Snow has over twenty years of experience investing in and advising public and private companies. He is currently President and Co-Portfolio Manager of Red Oak Partners, LLC, Miravo’s largest shareholder, and also serves as President and a director of CBA Florida, Inc. Before joining Red Oak Partners, Mr. Snow worked at Soros Fund Management where he was part of a two-person team that managed a global long/short equity portfolio. Before Soros, he also focused on global equities at both Ardea Capital Management, as part of the founding team, and Wyper Capital Management. Previously, Mr. Snow was an Associate at the private equity firm Lindsay Goldberg. Mr. Snow began his career at Merrill Lynch & Co. as an Analyst in the Mergers & Acquisitions group.
Mr. Snow received a B.B.A. with high distinction from the University of Michigan, concentrating in finance and accounting, and an M.B.A. from Harvard Business School.
About Miravo Healthcare
Miravo is a Canadian-focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company’s products target several therapeutic areas, including pain, allergy, neurology, and dermatology. The Company’s strategy is to in-license and acquires growth-oriented, complementary products for Canadian and international markets. Miravo head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company’s manufacturing facility is located in Varennes, Québec, Canada.
For more information: https://www.miravohealthcare.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.